James B. Jaquith

1.7k total citations · 1 hit paper
13 papers, 1.3k citations indexed

About

James B. Jaquith is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, James B. Jaquith has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in James B. Jaquith's work include Cell death mechanisms and regulation (3 papers), Asymmetric Synthesis and Catalysis (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). James B. Jaquith is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Asymmetric Synthesis and Catalysis (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). James B. Jaquith collaborates with scholars based in Canada, United States and France. James B. Jaquith's co-authors include Stephen J. Morris, John W. Gillard, Jon P. Durkin, Alain Boudreault, Kathleen M. Dickson, Philip A. Barker, Snezana Milutinovic, Mathieu J.M. Bertrand, Scott Collins and Shaotian Wang and has published in prestigious journals such as Nature, Nucleic Acids Research and Molecular Cell.

In The Last Decade

James B. Jaquith

13 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination

2008 874 citations Mathieu J.M. Bertrand, Snezana Milutinovic et al. Molecular Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James B. Jaquith Canada	10	992	449	322	236	162	13	1.3k
Chih-Min Kam United States	21	676 0.7×	273 0.6×	231 0.7×	361 1.5×	92 0.6×	35	1.3k
Masanori Okaniwa Japan	16	886 0.9×	236 0.5×	118 0.4×	229 1.0×	83 0.5×	26	1.4k
Ilaria Laurenzana Italy	22	962 1.0×	170 0.4×	523 1.6×	180 0.8×	83 0.5×	55	1.4k
Chudi Ndubaku United States	12	500 0.5×	375 0.8×	87 0.3×	282 1.2×	62 0.4×	22	932
Li‐Fan Zeng United States	23	1.0k 1.0×	536 1.2×	89 0.3×	252 1.1×	37 0.2×	43	1.4k
Luke H. Stockwin United States	18	585 0.6×	183 0.4×	189 0.6×	324 1.4×	55 0.3×	25	1.1k
Marc Abrams United States	22	1.1k 1.1×	163 0.4×	236 0.7×	281 1.2×	117 0.7×	41	1.6k
Alok R. Singh United States	16	494 0.5×	197 0.4×	177 0.5×	216 0.9×	41 0.3×	25	858
Rommel I. Tawatao United States	16	402 0.4×	439 1.0×	70 0.2×	123 0.5×	146 0.9×	20	997
Sanjeev Das India	19	668 0.7×	88 0.2×	268 0.8×	415 1.8×	134 0.8×	36	1.1k

Countries citing papers authored by James B. Jaquith

Since Specialization

Citations

This map shows the geographic impact of James B. Jaquith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James B. Jaquith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James B. Jaquith more than expected).

Fields of papers citing papers by James B. Jaquith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James B. Jaquith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James B. Jaquith. The network helps show where James B. Jaquith may publish in the future.

Co-authorship network of co-authors of James B. Jaquith

This figure shows the co-authorship network connecting the top 25 collaborators of James B. Jaquith. A scholar is included among the top collaborators of James B. Jaquith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James B. Jaquith. James B. Jaquith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Nielsen, Ole Haagen, Theresa Louise Boye, John Gubatan, et al.. (2023). Selective JAK1 inhibitors for the treatment of inflammatory bowel disease. Pharmacology & Therapeutics. 245. 108402–108402. 24 indexed citations

2.

Baradaran‐Heravi, Alireza, Aruna D. Balgi, Xiujuan Wu, et al.. (2020). Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency. Molecular Neurodegeneration. 15(1). 21–21. 26 indexed citations

3.

Baradaran‐Heravi, Alireza, Aruna D. Balgi, Carla Zimmerman, et al.. (2016). Novel small molecules potentiate premature termination codon readthrough by aminoglycosides. Nucleic Acids Research. 44(14). 6583–6598. 58 indexed citations

4.

Arns, Steve, Aruna D. Balgi, Yoko Shimizu, et al.. (2016). Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel. European Journal of Medicinal Chemistry. 120. 64–73. 13 indexed citations

5.

Zahreddine, Hiba Ahmad, Biljana Culjkovic‐Kraljacic, Sarit Assouline, et al.. (2014). The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation. Nature. 511(7507). 90–93. 149 indexed citations

6.

Jaquith, James B.. (2014). Targeting the Inhibitor of Apoptosis Protein BIR3 Binding Domains. Pharmaceutical Patent Analyst. 3(3). 297–312. 9 indexed citations

7.

Bertrand, Mathieu J.M., Snezana Milutinovic, Kathleen M. Dickson, et al.. (2008). cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination. Molecular Cell. 30(6). 689–700. 874 indexed citations breakdown →

8.

Galbán, Stefanie, Clara Hwang, Julie M. Rumble, et al.. (2008). Cytoprotective effects of IAPs revealed by a small molecule antagonist. Biochemical Journal. 417(3). 765–771. 38 indexed citations

9.

Jaquith, James B., et al.. (2002). Asymmetric Synthesis of the Highly Methylated Tryptophan Portion of the Hemiasterlin Tripeptides. Organic Letters. 4(5). 695–697. 38 indexed citations

10.

Jaquith, James B., et al.. (2002). Asymmetric Synthesis of the Highly Methylated Tryptophan Portion of the Hemiasterlin Tripeptides. Organic Letters. 4(11). 1979–1979. 2 indexed citations

11.

Levy, C.J., et al.. (2000). Asymmetric Catalysis of the Diels−Alder Reaction Using Dicationic Zirconocene Complexes. Organometallics. 19(6). 947–949. 9 indexed citations

12.

Jaquith, James B., et al.. (1998). Diels−Alder Reactions of Oxazolidinone Dienophiles Catalyzed by Zirconocene Bis(triflate) Catalysts: Mechanism for Asymmetric Induction. Organometallics. 17(5). 914–925. 31 indexed citations

13.

Jaquith, James B., et al.. (1995). Asymmetric Induction in the Diels-Alder Reaction Catalyzed by Chiral Metallocene Triflate Complexes: Dramatic Effect of Solvent Polarity. Organometallics. 14(3). 1079–1081. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact